Technical corrections only. The two versions of the bill, S. 1890, are substantively identical. The changes are limited to the document's legislative status and formatting, with no alterations to the bill's text or policy provisions.
Carla Walker Act
- Sponsor
- Sen. Cornyn, John [R-TX]
- Committees
- Judiciary Committee (primary)
- Last action
- Jun 15, 2026
Bottom line
The Carla Walker Act provides federal funding and establishes a regulatory framework for state and local law enforcement to expand their use of advanced forensic genetic genealogy techniques in criminal investigations and identifying human remains.
What it actually does
This bill establishes two new grant programs under the Omnibus Crime Control and Safe Streets Act of 1968 to enhance the use of forensic genetic genealogical (FGG) DNA analysis by state and local entities. One program funds FGG DNA analysis for physical evidence and unidentified human remains when traditional DNA databases fail, while the other funds equipment and database searching for FGG. It also sets strict requirements and limitations on how law enforcement can use FGG DNA analysis, including mandates for informed consent, data confidentiality, and compliance with Department of Justice policies.
Proponents argue
Supporters argue that this bill will significantly aid in solving cold cases and identifying victims by leveraging cutting-edge forensic technology, especially when traditional methods have been exhausted. They emphasize that the included safeguards, such as requiring CODIS searches first, obtaining informed consent, and ensuring data confidentiality, protect privacy while still allowing for effective law enforcement tools. The bill provides necessary funding for smaller agencies to access these advanced techniques.
Opponents contend
Critics might raise concerns about the privacy implications of expanding law enforcement access to genetic genealogy databases, even with the stated safeguards. They may argue that the potential for misuse or unintended consequences, such as the creation of broad genetic surveillance capabilities, outweighs the benefits. Some may also question the effectiveness of "informed consent" when dealing with third-party genetic data or the potential for bias in how these technologies are applied.
The bill is moderately detailed but accessible, allowing a reader to understand its core provisions and implications within a reasonable timeframe.
Section 2, adding new Section 3062 to Title I of the Omnibus Crime Control and Safe Streets Act of 1968.
Grants for Advanced DNA Analysis (FGG DNA Analysis)
This provision authorizes competitive grants for state and local entities to conduct advanced DNA analyses using whole genome sequencing technology compatible with genealogical databases. These analyses are specifically for physical evidence or unidentified human remains when searches in the Combined DNA Index System (CODIS) have failed to produce leads. Funds can also be used to outsource these specialized analyses.
Supporters argue
Supporters argue this grant program directly addresses the need for advanced tools in difficult cases, providing resources to agencies that might not otherwise afford them. It ensures that all avenues are explored to bring justice to victims and closure to families.
Critics contend
Critics might argue that while the goal is laudable, the focus on FGG DNA analysis might divert resources from other critical forensic needs or raise privacy concerns if not rigorously managed.
Tradeoffs
Balances the desire to solve difficult cases with the need to ensure responsible and ethical use of advanced genetic technologies.
Section 2, adding new Section 3062(e) to Title I of the Omnibus Crime Control and Safe Streets Act of 1968.
Safeguards and Ethical Guidelines for Genetic Genealogy Use
This section establishes a detailed set of rules for entities receiving grants when using FGG DNA analysis. Key requirements include first searching CODIS, identifying as law enforcement to genetic genealogy services, using services that notify users of law enforcement access, seeking informed consent for reference samples (unless impractical), maintaining confidentiality, and prohibiting the use of genetic data for medical or psychological trait determination.
Section 2, adding new Section 3063 to Title I of the Omnibus Crime Control and Safe Streets Act of 1968.
Grants for FGG Equipment and Database Access
This provision authorizes grants for eligible entities (publicly funded accredited forensic laboratories, prosecutor's offices with lab capability, medical examiners, and coroners) to purchase equipment necessary for FGG DNA analysis and searching. Funds can also be used to pay for access to genealogical databases to generate investigative leads for criminal cases or unidentified human remains.
Section 2, adding new Sections 3064 and 3065 to Title I of the Omnibus Crime Control and Safe Streets Act of 1968.
Accountability and Performance Reporting
These sections establish administrative provisions for the grant programs, including the Attorney General's authority to promulgate regulations. Grant recipients are required to maintain detailed records for audit purposes and submit comprehensive annual reports to the Attorney General. These reports must include data on funding use, the number of cases submitted for FGG analysis, the types of testing performed, and the outcomes of FGG searches, such as lead generation and identification rates.
Defines "accredited forensic laboratory" to include facilities that are currently accredited by an internationally recognized body, or those that attest in a legally binding manner to apply for such accreditation within 2 years of receiving a grant or a request for analysis from a grant recipient.
Section 2, adding new Section 3061(1) to Title I of the Omnibus Crime Control and Safe Streets Act of 1968.
Why it matters:This is standard legislative practice to define terms upfront, but its operational impact is substantial.
Case for: Supporters argue this ensures a high standard of quality and reliability for forensic analyses conducted under the grant programs, promoting best practices in forensic science.
Case against: Critics might contend that the 2-year window for accreditation could allow unaccredited labs to perform sensitive analyses for a period, potentially compromising early investigations or creating a barrier for smaller labs to participate.
Estimated impact: Ensures quality control for all FGG DNA analysis funded by the grants, affecting potentially hundreds of labs nationwide.
Explicitly prohibits the use of biological samples or forensic genetic genealogy profiles to determine genetic predisposition for disease or any other medical condition or psychological trait of the donor.
Section 2, adding new Section 3062(e)(10) to Title I of the Omnibus Crime Control and Safe Streets Act of 1968.
Why it matters:While important, it's a specific limitation within a broader set of operational rules, so its placement is not necessarily evasive but could be missed.
Case for: Proponents emphasize this as a vital safeguard against mission creep and potential discrimination, ensuring that genetic data collected for law enforcement identification purposes is not used for health or psychological profiling.
Case against: No direct opposition, as this is a widely accepted ethical boundary.
Estimated impact: Prevents a significant expansion of government use of genetic data into highly sensitive personal health information.